drugset / Trial / NCT05889455

Effect of Sildenafil in Individuals With Migraine Pretreated With Erenumab

NCT05889455

RandomizedCrossoverQuadruple-blindOther

Summary

An outstanding scientific question, that merits further investigation, is whether dilation of intracranial arteries is implicated in the pathogenesis of cephalic pain in migraine. Here, we hypothesize that experimentally-induced dilation of intracranial arteries using intake of sildenafil (a potent vasodilator) can induce cephalic pain with migraine-like features in people with migraine, who prior to the infusion are administered erenumab (anti-calcitonin gene-related peptide (CGRP) receptor monoclonal antibody.

Timeline

Start
2023-04-20
Primary completion
2023-10-12
Completion
2023-10-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 100 mg Oral

Indications